Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
07/2004
07/08/2004WO2004056182A1 Pesticidal dibenzo(hetero)azepine derivatives
07/08/2004US20040133012 For use as anesthetics and as neuroprotective agents; prevents the formation of the toxic metabolite, 2-phenyl-acrylamide
07/08/2004US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
07/08/2004US20040132717 2-Oxo-piperidinyl-and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders
07/08/2004US20040131885 Organic electroluminescent device and organic electroluminescent compound thereof
07/07/2004CN1511141A Method for preparation of 10,11-dihydro-10-hydroxy-5H-dibenz/B, F/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B, F/azepine-5-carboxamide
07/06/2004US6759404 Inhibiting gamma-secretase activity; treating diseases associated with beta-amyloid production, such as alzheimer's disease
07/01/2004WO2004017911A3 Protease inhibitors
07/01/2004WO2003106414A3 Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
07/01/2004US20040127569 involving an overproduction of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) by administering to the subject an anti-inflammatory effective amount of an inducible nitric oxide synthase selective inhibitor
07/01/2004US20040127528 Metalloproteinase inhibitors
07/01/2004US20040127482 Substituted heterocycle fused gamma-carbolines
06/2004
06/30/2004EP1070049B1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
06/30/2004CN1509288A The citrate salt of 5,8,14-triazatetracyclo (10.3.1.0.2,11.0.4,9)-hexadeca-2.(11),3,5,7,9-pentaene
06/30/2004CN1509286A Metalloproteinase inhibitors
06/30/2004CN1509276A Metalloproteinase inhibitors
06/30/2004CN1509275A Metalloproteinase inhibitors
06/30/2004CN1509272A Metalloproteinase inhibitors
06/30/2004CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene
06/30/2004CN1508128A Method for preparing caprolactam
06/30/2004CN1155577C Caprolactam extracting and direct steam benzene-removing process
06/29/2004US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/24/2004WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators
06/24/2004US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide
06/23/2004EP1430031A2 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
06/23/2004EP1429777A1 Ophthalmologic treatment methods using selective inos inhibitors
06/23/2004EP1429752A1 Neuroprotective treatment methods using selective inos inhibitors
06/22/2004US6753429 1,4-disubstituted benzenes as insecticides
06/17/2004WO2003097050A3 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
06/16/2004CN1505606A Production of 6-aminocaproic acid
06/16/2004CN1504480A Endothelin receptor antagonist of tripeptide
06/15/2004US6750238 Aralkyl ester soft drugs
06/10/2004US20040110793 Heterocyclo inhibitors of potassium channel function
06/09/2004EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/09/2004CN1503779A Production of alkyl 6-aminocaproate
06/09/2004CN1152859C Novel N-vinyllactam derivatives and polymer thereof
06/09/2004CN1152858C Method for simultaneously producing cyclic lactam and cyclic amine
06/09/2004CN1152856C Separation of 6-aminocaproic acid nitrile from mixtures containing 6-aminocaproic acid and imine
06/08/2004US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease
06/03/2004WO2004045536A2 Method and compositions for temporarily incapaciting subjets
06/03/2004WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/03/2004WO2004012726A3 Methods for treatment and prevention of gastrointestinal conditions
06/03/2004US20040106788 asymmetric hydrogenation of a lactam-enamide; multi-step synthesis
06/03/2004US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione
06/03/2004US20040106593 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
06/03/2004US20040105813 novel process for reacting at least two fluids; process comprises supplying at least two fluids into mixing chamber through conduits leading thereto in tangential and radial directions; production of hydrogen peroxide from hydrogen and oxygen
06/03/2004CA2503316A1 Method and compositions for temporarily incapacitating subjects
06/03/2004CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/02/2004EP1423369A1 Process for distilling alkaline caprolactam product at reduced pressure
06/02/2004CN1500787A Cyclic nitrones and pharmaceutical compositions containing them
06/02/2004CN1500779A Cyclic nitrones and pharmaceutical compositions containing them
06/02/2004CN1152030C Novel heterocyclic compounds
06/02/2004CN1152017C Caprolactam hydrofining process for circulated catalyst
06/02/2004CN1151965C Method for distilling ammonia
06/01/2004US6743912 Storage and transportation of N-vinyl-epsilon-caprolactam
06/01/2004US6743911 Pentenenitrile reacted with carbon monoxide and water or alcohol in the presence of a source of group viii metal and a bidentate phosphine, arsine and/or stibine ligand to form cyanovaleric acid or ester
06/01/2004US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α
05/2004
05/27/2004WO2004043939A1 Amide compounds and methods of using the same
05/27/2004WO2003088908A3 Heterocyclo inhibitors of potassium channel function
05/27/2004US20040102431 Protease inhibitors
05/27/2004US20040100188 Anthracene derivative and organic electroluminescence device using the derivative
05/26/2004EP1422228A1 BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE
05/21/2004WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
05/21/2004CA2503844A1 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
05/20/2004US20040097726 While suppressing oxime hydrolysis; continuous processing; high temperature/pressure
05/20/2004US20040097699 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
05/20/2004US20040097550 For therapy of thrombosis, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases
05/19/2004CN1498206A Biurethane derivatives
05/19/2004CN1496981A Cycloamine derivative and its use as medicine
05/19/2004CN1150061C Method for preparing zeolite catalyst
05/12/2004EP1242375B1 Method for purifying lactames
05/12/2004CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia
05/11/2004US6734323 Mixing suspension resulting from synthesis of zeolite with an oligomeric silica sol obtained from the hydrolysis of a tetra-alkyl ortho silicate in the presence of a tetra-alkylammonium hydroxide, rapid spray drying
05/11/2004US6734186 Phosphodiesterase 2 inhibitor
05/06/2004WO2004037788A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists
05/06/2004US20040087653 Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor
05/06/2004US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents
05/06/2004US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists
05/06/2004EP1414806A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc
04/2004
04/29/2004WO2004035544A1 Benzo[d]azepine derivatives for the treatment of neurological and psychiatric disorders
04/29/2004WO2003104282A8 Glycoprotein vi - fc fusion protein for treating vascular disorders
04/29/2004WO2003003972A3 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
04/29/2004US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
04/29/2004US20040082575 Compounds and methods for modulation of estrogen receptors
04/29/2004US20040082559 Vitronectin receptor antagonists
04/28/2004EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS
04/28/2004EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them
04/28/2004CN1491951A Intermediate of azepine
04/27/2004US6727255 Brain, nervous system and psychological disorders
04/27/2004US6727241 Inhibit the binding of various chemokines, such as mip-1 alpha and rantes, to the ccr1 receptor
04/22/2004WO2002074767A8 Metalloproteinase inhibitors
04/22/2004WO2002074748A8 Metalloproteinase inhibitors
04/22/2004US20040077865 Making 1-amino-6-nitroisoquinoline by reacting beta-(dimethylamino)-2-cyano-5-nitro-styrene with lithium hexamethyldisilazane or reacting said styrene compound with 2,4-dimethoxybenzylamine and then with anisole
04/22/2004US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome
04/22/2004US20040077639 Administering amidine derivative as antiasthmatic agents; chronic obstructive pulmonary disease treatment
04/21/2004EP0877736B1 Benzazepine derivatives with vasopressin agonistic activity
04/21/2004CN1490314A Preparation of hexanolactam
04/21/2004CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 88